Pharmaceutical company Pfizer will request permission from the US and European drug agencies to administer a third dose of its corona vaccine. But weren’t we recently told that two doses provide sufficient protection, including against the delta variant? Will we all have to go to the vaccination center a third time, or will that third round be reserved for high-risk groups? Our country is already working on a plan for target three.
–
Pfizer’s own research should suggest the best: a third dose of their corona vaccine increases the number of antibodies against the virus by five to ten times. So the producer will soon be …
– .
